scholarly journals PCN90 - COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF NILOTINIB FOR THE SECOND LINE TRATMENT OF CHRONIC MIELOID LEUKEMIA IN THE RUSSIAN FEDERATION

2018 ◽  
Vol 21 ◽  
pp. S29
Author(s):  
N.A. Avxentyev ◽  
M.Y. Frolov ◽  
A.S. Makarov
Sign in / Sign up

Export Citation Format

Share Document